Karolinska Development AB
Overview
Karolinska Development AB is a Nordic life sciences investment company specializing in identifying and developing breakthrough medical innovations in the Nordic region. The company invests in the creation and growth of companies that advance these assets into commercial products designed to make a difference to patients' lives while providing an attractive return on investment to shareholders. Karolinska Development has access to world-class medical innovations at the Karolinska Institutet and other leading universities and research institutes in the Nordic region. The company aims to build companies around scientists who are leaders in their fields, supported by experienced management teams and advisers, and co-funded by specialist international investors, to provide the greatest chance of success. Karolinska Development has established a portfolio of eleven companies targeting opportunities in innovative treatment for life-threatening or serious debilitating diseases. The company is led by an entrepreneurial team of investment professionals with a proven track record as company builders and with access to a strong global network.
Investment Focus
- Focus on life sciences companies developing innovative treatments for serious diseases
- Strong management teams with expertise in their respective fields
- Potential for significant return on investment
Portfolio Companies
Reach Karolinska Development AB directly
Verified work email, phone and LinkedIn for the full team — one spreadsheet, one payment, yours to keep.
Unlock full contacts →Frequently asked questions about Karolinska Development AB
What sectors does Karolinska Development AB invest in?
Karolinska Development AB invests in Healthcare, Pharmaceuticals, Medical Devices, Biotechnology, Healthcare Technology and Medical Research, and is based in Stockholm County, Sweden. Karolinska Development AB is listed as a venture capital in the ConnectSafely investor database.
What stage does Karolinska Development AB invest at?
Karolinska Development AB backs companies at Seed, Early Stage and Growth, writing cheques of 1M - 50M.
Which regions does Karolinska Development AB invest in?
Karolinska Development AB invests across Denmark, Sweden, Norway, Finland and Iceland.
What companies has Karolinska Development AB invested in?
Karolinska Development AB's portfolio includes Forendo Pharma, OssDsign, Modus Therapeutics, BOOST Pharma, Umecrine Cognition, Dilafor, Aprea Therapeutics and Lipidor.
Last updated · Source: ConnectSafely investor database
